Fig 1.
Design of the prospective cohort study, FemCure.
Table 1.
Themes and strategies (derived from previous studies 23–31) employed in the prospective multicenter FemCure study, aimed to maximize women’s participation.
Table 2.
Baseline characteristics distributions in the target population, (not) preselected women, (not) included women, and women retained in the study, FemCure.
Fig 2.
Kaplan–Meier survival function (line) with 95% confidence intervals (grey area) on the probability of being retained, and the number of women retained (“Number at Risk”) in the FemCure study.
Table 3.
Odds ratios for the association between characteristics and non-preselection among STI clinic women target population, and noninclusion among preselected women, and noninclusion among the target population, FemCure.
Table 4.
Attrition (i.e., patients lost to follow-up or withdrawn) rates and Hazard Ratios, FemCure during the 3-month follow-up period (Apr. 2016–Dec. 2017).
Table 5.
End of follow-up study evaluation responses from the retained participants in the prospective multicenter FemCure cohort study on Chlamydia trachomatis in women.